Neocis, the company behind the first US FDA-cleared robotic system for dental implant surgery, has announced the launch and FDA approval of its latest robotic platform, Yomi S. The system incorporates an updated design and new software capabilities intended to support clinicians in planning and performing implant procedures.
Yomi S includes a smaller physical footprint, revised ergonomics, and an AI-enabled planning suite known as YomiPlan. According to the company, the system can be operated by a single practitioner using a foot pedal and touchscreen interface, which may help streamline workflows and reduce the need for additional clinical staff during procedures.
Features and planning capabilities
The YomiPlan software uses machine learning algorithms to assist clinicians with tasks such as anatomical segmentation from CBCT scans, including identifying structures such as nerves and sinuses. These tools are designed to support the planning of implant placement and other potential applications. The platform also incorporates updated cybersecurity and medical software features in line with current FDA guidance.
Clinical use and practitioner feedback
Several practitioners have commented on their experience with the system. Dr Jay Neugarten, DDS, MD, FACS, notes that the revised range of motion, reach, and interface options — including touchscreen and voice commands — have contributed to procedural efficiency while maintaining accuracy. Individual practitioner experiences may vary depending on case complexity, workflow, and training.
Potential impact on clinical workflows
The company states that the system is intended to support a range of clinical scenarios, including single-operator use, which may help practices manage resources more effectively. Yomi S is also designed to expand the range of procedures that can be performed with robotic assistance, although these applications will depend on regulatory clearance, clinical protocols, and practitioner adoption.
Patient experience and minimally invasive approach
One of the aims of Yomi S is to support minimally invasive, flapless implant placement. According to the manufacturer, real-time navigation and guidance are designed to help clinicians avoid critical anatomical structures and maintain accuracy throughout the procedure. Some patients have reported positive experiences with earlier versions of the system, including reduced discomfort and shorter recovery periods.
In one example, a Yomi patient, Anders Brag, described his procedure as “painless” and noted less post-operative discomfort compared with previous implant treatment. Individual outcomes, however, depend on multiple clinical factors.
Company perspective
Neocis describes Yomi S as part of a broader effort to make robotic-assisted implant surgery more accessible across different practice types. According to founder and CEO Alon Mozes, the updated system emphasises ease of use and integrates design changes intended to simplify adoption. The company reports that nearly 100,000 osteotomies have been completed with its robotic systems to date.
Summary
The introduction of Yomi S represents the latest development in computer-assisted dental implant technology, combining updated hardware with AI-supported planning tools. While feedback from clinicians and patients highlights several potential benefits — such as workflow efficiency, precision, and comfort — its impact will continue to evolve as adoption increases and as further clinical data becomes available.
Source: Globe Newswire
